One-carbon metabolism biomarkers and risk of colon and rectal cancers.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2656360)

Published in Cancer Epidemiol Biomarkers Prev on November 01, 2008

Authors

Stephanie J Weinstein1, Demetrius Albanes, Jacob Selhub, Barry Graubard, Unhee Lim, Philip R Taylor, Jarmo Virtamo, Rachael Stolzenberg-Solomon

Author Affiliations

1: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Nutritional Epidemiology Branch, Suite 320, 6120 Executive Boulevard, Bethesda, MD 20892, USA. weinstes@mail.nih.gov

Articles citing this

Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2009) 1.11

p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev (2009) 1.10

Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.05

A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiol Biomarkers Prev (2009) 1.02

Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.01

Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr (2013) 0.92

Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control (2012) 0.92

Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev (2009) 0.89

Vitamin B6 and colorectal cancer: current evidence and future directions. World J Gastroenterol (2013) 0.87

Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PLoS One (2015) 0.85

Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis (2014) 0.84

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation. Cancer Epidemiol Biomarkers Prev (2010) 0.82

Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population. Am J Clin Nutr (2009) 0.81

Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol (2015) 0.80

Plasma folate concentrations and colorectal cancer risk: a case-control study nested within the Shanghai Men's Health Study. Int J Cancer (2014) 0.79

Intraindividual variation in one-carbon metabolism plasma biomarkers. Cancer Epidemiol Biomarkers Prev (2013) 0.78

Genetic variants in 3'-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans. Sci Rep (2015) 0.78

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study. Int J Cancer (2015) 0.77

Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex. Am J Cancer Res (2014) 0.77

Untangling the role of one-carbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysis. Sci Rep (2017) 0.75

Circulating folate levels and colorectal adenoma: a case-control study and a meta-analysis. Nutr Res Pract (2017) 0.75

Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-Up Study cohort. Int J Cancer (2016) 0.75

Articles cited by this

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol (1994) 6.47

Glutathione metabolism and its implications for health. J Nutr (2004) 6.27

Are there two sides to colorectal cancer? Int J Cancer (2002) 5.18

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

Homocysteine metabolism. Annu Rev Nutr (1999) 3.75

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1987) 3.58

Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36

Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91

Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol (1988) 2.53

Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr (2002) 2.52

The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40

Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer (2005) 2.11

Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res (2007) 1.89

Folate status: effects on pathways of colorectal carcinogenesis. J Nutr (2002) 1.88

Folate and cancer--timing is everything. JAMA (2007) 1.88

Folate metabolism and requirements. J Nutr (1999) 1.66

Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res (2003) 1.60

Low folate levels may protect against colorectal cancer. Gut (2006) 1.60

Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study. Cancer Causes Control (2007) 1.59

Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer (2002) 1.55

Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52

Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr (1994) 1.45

Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol (1991) 1.37

Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst (2005) 1.36

Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol (2005) 1.36

A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 1.31

The effects of alcohol on folate metabolism. Annu Rev Med (1982) 1.30

The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2005) 1.30

Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev (1996) 1.30

Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol (2005) 1.27

Nutritional status of folate and colon cancer risk: evidence from NHANES I epidemiologic follow-up study. Ann Epidemiol (2001) 1.24

Monitoring micronutrients in cigarette smokers. Clin Chim Acta (2006) 1.21

Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. Cancer Epidemiol Biomarkers Prev (2000) 1.20

Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.18

Vitamin B6-mediated suppression of colon tumorigenesis, cell proliferation, and angiogenesis (review). J Nutr Biochem (2003) 1.09

The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr (2002) 1.05

Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study. Int J Cancer (2008) 1.02

Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr (2007) 1.01

Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States. Cancer Causes Control (2002) 0.95

The transport of thiamine, riboflavin and pyridoxal 5'-phosphate by human placenta. Int J Vitam Nutr Res (1992) 0.92

Vitamin B6 intake, alcohol consumption, and colorectal cancer: a longitudinal population-based cohort of women. Gastroenterology (2005) 0.92

Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr (2001) 0.91

Vitamin B6 and immune competence. Nutr Rev (1993) 0.88

Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol (1986) 0.86

Articles by these authors

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst (2006) 4.95

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med (2002) 4.87

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69

Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr (2007) 4.37

Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med (2004) 4.34

A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A (2002) 4.22

Tissue-resident macrophages. Nat Immunol (2013) 4.09

Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93

Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med (2005) 3.17

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med (2009) 3.12

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91

Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87

Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87

Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71

Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2006) 2.64

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res (2006) 2.53

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes (2008) 2.50

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA (2003) 2.50

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst (2006) 2.48

A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res (2009) 2.48

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40

Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol (2003) 2.38

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation (2010) 2.32

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer (2007) 2.29

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med (2005) 2.29

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr (2006) 2.25

Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med (2007) 2.23

Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res (2005) 2.22

Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA (2002) 2.19

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis (2009) 2.17